COVID-19 and diabetes: Knowledge in progress

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Song, 2019, From SARS to MERS, thrusting coronaviruses into the spotlight, Viruses, 11, 10.3390/v11010059 World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it 2020 [31/03/2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it. Ceccarelli, 2020, Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet?, Eur Rev Med Pharmacol Sci, 24, 2781 World Health Organization. Rolling updates on coronavirus disease (COVID-19) 2020 [31/03/2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen. World Health Organization. Coronavirus disease (COVID-19) Pandemic 2020 [02/04/2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 1 Lauer, 2020, The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application, Ann Intern Med, 10.7326/M20-0504 Centers for Diasease Control and Prevention. Symptoms of Coronavirus 2020 [cited 31/03/2020]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html. Jalava, 2020, First respiratory transmitted food borne outbreak?, Int J Hyg Environ Health, 226, 10.1016/j.ijheh.2020.113490 Guo, 2020, The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status, Mil Med Res, 7, 11 Adhikari, 2020, Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review, Infect Dis Poverty, 9, 29, 10.1186/s40249-020-00646-x van Doremalen, 2020, Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1, N Engl J Med, 10.1056/NEJMc2004973 World Health Organization. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations 2020 [30/03/2020]. Available from: https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations. Zou, 2020, SARS-CoV-2 viral load in upper respiratory specimens of infected patients, N Engl J Med, 382, 1177, 10.1056/NEJMc2001737 Liu, 2020, Viral dynamics in mild and severe cases of COVID-19, Lancet Infect Dis Rothe, 2020, Transmission of 2019-nCoV infection from an asymptomatic contact in Germany, N Engl J Med, 382, 970, 10.1056/NEJMc2001468 Wang, 2020, Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China, JAMA, 10.1001/jama.2020.1585 Zhang, 2020, Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China, Allergy, 10.1111/all.14238 Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention, JAMA, 323, 1239, 10.1001/jama.2020.2648 Giacomelli, 2020, Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study, Clin Infect Dis, 10.1093/cid/ciaa330 Shi, 2020, Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study, Lancet Infect Dis, 20, 425, 10.1016/S1473-3099(20)30086-4 World Health Organization. Coronavirus disease (COVID-19) technical guidance: Laboratory testing for 2019-nCoV in humans 2020 [30/03/2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance. Li, 2020, Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis, J Med Virol Centers for Disease Control and Prevention. Updated Guidance on Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19). 2020 [30/03/2020]. Available from: https://emergency.cdc.gov/han/2020/han00429.asp. Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 10.1016/S0140-6736(20)30566-3 Yang, 2020, Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis, Int J Infect Dis, 10.1016/j.ijid.2020.03.017 Li, 2020, Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China, Clin Res Cardiol, 10.1007/s00392-020-01626-9 Onder, 2020, Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy, JAMA, 10.1001/jama.2020.4683 Williams, 2020, Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas, Diabetes Res Clin Pract, 162, 10.1016/j.diabres.2020.108072 Pearson-Stuttard, 2016, Diabetes and infection: assessing the association with glycaemic control in population-based studies, Lancet Diabetes Endocrinol, 4, 148, 10.1016/S2213-8587(15)00379-4 McDonald, 2014, New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records, Diabet Med, 31, 606, 10.1111/dme.12384 Li, 2019, Diabetes mellitus and cause-specific mortality: a population-based study, Diabetes Metab J, 43, 319, 10.4093/dmj.2018.0060 Knapp, 2013, Diabetes and infection: is there a link? - A mini-review, Gerontology, 59, 99, 10.1159/000345107 Schoen, 2019, Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity, BMC Infect Dis, 19, 10.1186/s12879-019-4592-0 Yang, 2006, Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS, Diabet Med, 23, 623, 10.1111/j.1464-5491.2006.01861.x Banik, 2016, Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia, Virol Sin, 31, 81, 10.1007/s12250-015-3679-z Lippi, 2020, Laboratory abnormalities in patients with COVID-2019 infection, Clin Chem Lab Med, 10.1515/cclm-2020-0198 Wang, 2020, Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed, Diabetes Res Clin Pract, 162, 108118, 10.1016/j.diabres.2020.108118 Zhou, 2020, Diabetes patients with COVID-19 need better care, Metabolism, 10.1016/j.metabol.2020.154216 Iqbal, 2019, Effect of hypoglycemia on inflammatory responses and the response to low-dose endotoxemia in humans, J Clin Endocrinol Metab, 104, 1187, 10.1210/jc.2018-01168 Petrie, 2018, Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms, Canadian J Cardiol, 34, 575, 10.1016/j.cjca.2017.12.005 Geerlings, 1999, Immune dysfunction in patients with diabetes mellitus (DM), FEMS Immunol Med Microbiol, 26, 259, 10.1111/j.1574-695X.1999.tb01397.x Moutschen, 1992, Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections, Diabete Metab, 18, 187 Ilyas, 2011, High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus, Immunobiology, 216, 126, 10.1016/j.imbio.2010.06.002 Kohio, 2013, Glycolytic control of vacuolar-type ATPase activity: a mechanism to regulate influenza viral infection, Virology, 444, 301, 10.1016/j.virol.2013.06.026 Popov, 1997, Alterations of lung structure in experimental diabetes, and diabetes associated with hyperlipidaemia in hamsters, Eur Respir J, 10, 1850, 10.1183/09031936.97.10081850 Lange, 1989, Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study, Eur Respir J, 2, 14, 10.1183/09031936.93.02010014 Dunn, 2005, Type 2 diabetes: an atherothrombotic syndrome, Curr Mol Med, 5, 323, 10.2174/1566524053766059 Letko, 2020, Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses, Nat Microbiol, 5, 562, 10.1038/s41564-020-0688-y Li, 2003, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, 426, 450, 10.1038/nature02145 Yang, 2010, Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes, Acta Diabetol, 47, 193, 10.1007/s00592-009-0109-4 Henry, 2018, Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia, Bayl Univ Med Cent Proc, 31, 419, 10.1080/08998280.2018.1499293 Mortensen, 2008, Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia, Eur Respir J., 31, 611, 10.1183/09031936.00162006 Gullestad, 1999, Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure, J Am Coll Cardiol, 34, 2061, 10.1016/S0735-1097(99)00495-7 Chamberlain, 2016, Diagnosis and management of diabetes: synopsis of the 2016 American diabetes association standards of medical care in diabetes, Ann Intern Med, 164, 542, 10.7326/M15-3016 Zheng, 2020, COVID-19 and the cardiovascular system, Nat Rev Cardiol, 10.1038/s41569-020-0360-5 Gurwitz, 2020, Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics, Drug Dev Res., 10.1002/ddr.21656 Kuba, 2005, A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat Med, 11, 875, 10.1038/nm1267 Peng, 2020, Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV, Zhonghua Xin Xue Guan Bing Za Zhi, 48, E004 Qiao, 2015, Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats, Cardiology, 131, 97, 10.1159/000375362 Zhang, 2013, Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitis, Ann Hepatol, 12, 892, 10.1016/S1665-2681(19)31294-3 Fadini, 2020, Prevalence and impact of diabetes among people infected with SARS-CoV-2, J Endocrinol Invest, 10.1007/s40618-020-01236-2 Wang, 2017, Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013, JAMA, 317, 2515, 10.1001/jama.2017.7596 Longato, 2020, Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region (North East Italy), Nutr Metab Cardiovasc Dis, 30, 84, 10.1016/j.numecd.2019.08.017 Gentile, 2020, COVID-19 infection in Italian people with diabetes: lessons learned from our future (an experience to be used), Diabetes Res Clin Pract, 162, 10.1016/j.diabres.2020.108137 Li, 2020, Updated approaches against SARS-CoV-2, Antimicrob Agents Chemother World Health Organization. Overview of the types/classes of candidate therapeutics 2020 [28/03/2020]. Available from: https://www.who.int/blueprint/priority-diseases/key-action/Table_of_therapeutics_Appendix_17022020.pdf?ua=1. Wang, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res., 30, 269, 10.1038/s41422-020-0282-0 Gao, 2020, Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies, Biosci Trends., 14, 72, 10.5582/bst.2020.01047 Rekedal, 2010, Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases, Arthritis Rheum, 62, 3569, 10.1002/art.27703 Gerstein, 2002, The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas–a randomized trial, Diabetes Res Clin Pract, 55, 209, 10.1016/S0168-8227(01)00325-4 Kumar, 2018, Efficacy and safety of hydroxychloroquine when added to stable insulin therapy in combination with metformin and glimepiride in patients with type 2 diabetes compare to sitagliptin, Int J Basic Clin Pharmacol, 7, 1959, 10.18203/2319-2003.ijbcp20183930 Emami, 1998, Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats, Life Sci, 64, 325, 10.1016/S0024-3205(98)00568-2 Russell, 2020, Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury, Lancet, 395, 473, 10.1016/S0140-6736(20)30317-2 Arabi, 2017, Middle east respiratory syndrome, N Engl J Med., 376, 584, 10.1056/NEJMsr1408795 Stockman, 2006, SARS: systematic review of treatment effects, PLoS Med, 3, e343, 10.1371/journal.pmed.0030343 Arabi, 2018, Corticosteroid therapy for critically Ill patients with middle east respiratory syndrome, Am J Respir Crit Care Med., 197, 757, 10.1164/rccm.201706-1172OC World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance, 13 March 2020 Geneva2020 [28/03/2020]. Available from: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930317-2. Clore, 2009, Glucocorticoid-induced hyperglycemia, Endocr Pract, 15, 469, 10.4158/EP08331.RAR